Hedge funds and other institutional investors own 42.24% of the company’s stock. Shares of Oncomed Pharmaceuticals Inc (NASDAQ:OMED) opened at 10.28 on Thursday. The stock’s market capitalization is …
BNS8d
Sells
Oncomed Pharmaceuticals Inc (NASDAQ:OMED) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday. According to Zacks, “OncoMed Pharmaceuticals, …
OncoMed Pharmaceuticals, Inc. OMED was a big mover last session, as the company saw its shares rise 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal …
The total asset value for OMED stock as of year is $237.88M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech …
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors …
Monkey
ETFs by nature are passive index-followers, so as long as the stock remains in the index, it doesn't much matter whether analysts find the stock overvalued or undervalued. Below are some of the ETFs that hold OMED at …
Below is a chart showing TGTX's trailing twelve month trading history, with the $10 strike highlighted in orange: Today's Most Active Call & Put Options of the S&P 500 » OncoMed Pharmaceuticals Inc. (OMED) saw …
underlying shares
ABIO stock jumped over 43%, while OMED stock and IMMU stock each gained just under 8%. Finally, MACK stock tacked on nearly 7%. Of the biggest movers in the world of pharma-related small caps stocks, only …
Oculus